HA330 одноразовый гемоперфузионный картридж

HA330 одноразовый гемоперфузионный картридж

Показания к применению

Сепсис и септический шок

Синдром системного воспалительного ответа (SIRS)

Тяжелые инфекционные заболевания

Новая коронавирусная инфекция COVID-19 (SARS-CoV-2)

Спецификация

Наименование модели	НА 330
Показание для применения	Критические состояния
Объём картриджа (мл)	330 ± 3
Свободный объём (мл)	185 ± 5
Абсорбирующий материал	Сополимер стирола и дивинилбензола
Материал корпуса	Поликарбонат
Заполняющий раствор	Стерильная вода
Метод стерилизации	Стерилизация облучением

Рекомендации по применению

Картридж для гемоперфузии одноразовый стерильный серии HA, производства Jafron Biomedical Co., Ltd.

Материалы для скачивания

Применение гемоперфузионных картриджей НА330, Jafron Biomedical Со., КНР, для лечения тяжелых случаев COVID-19

Список литературы

Соколов А. А. и др. Методы экстракорпоральной гемокоррекции в комплексном лечении новой коронавирусной инфекции: обзор возможностей //Вестник анестезиологии и реаниматологии. – 2020. – Т. 17. – №. 4. – С. 31-40.

Clark W. R. et al. Extracorporeal sorbent technologies: basic concepts and clinical application //Current Perspectives in Kidney Diseases. – Karger Publishers, 2017. – Т. 190. – С. 43-57.

Cytokine adsorption devices for treating respiratory failure in people with COVID-19

Haidari Z. et al. Intraoperative hemoadsorption in patients with native mitral valve infective endocarditis //The Annals of Thoracic Surgery. – 2020.

Huang Z. et al. Effect on Extrapulmonary Sepsis‐Induced Acute Lung Injury by Hemoperfusion With Neutral Microporous Resin Column //Therapeutic Apheresis and Dialysis. – 2013. – Т. 17. – №. 4. – С. 454-461.

Huang Zhao Wang Sirong, ji-yun liu. Blood perfusion treatment of sepsis the removal of inflammatory markers in patients with acute kidney injury and renal protection [J]. Chinese journal of emergency medicine, 2011, 20 (1) : 60-64.

Jafron Oversea Clinical Cases Collection

Kellum J. A., Bellomo R., Ronco C. (ed.). Continuous renal replacement therapy. – Oxford University Press, 2016.

Krenn C. G., Steltzer H. Hämoadsorption zur Blutreinigung–Unvergleichbarkeit der klinisch angebotenen Verfahren //Medizinische Klinik-Intensivmedizin und Notfallmedizin. – 2020. – С. 1-5.

Li W. H. et al. Curative effect of neutral macroporous resin hemoperfusion on treating hemodialysis patients with refractory uremic pruritus //Medicine. – 2017. – Т. 96. – №. 12.

Mao Huljuan, Yu Shu, Zhang Bo, et al. Effects of coupled plasma filtration adsorption on serum cytokines in patients with multiple organ dysfunction syndromes [J]. Chinese Journal of Blood Unification, 2009 (8)2: 70-75.

Nalesso F. et al. A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19//Journal of Clinical Medicine. – 2020. – Т. 9. – №. 5. – С. 1529

OCTAVIANO C., Alolod M. K. SUN-229 CLINICAL OUTCOMES OF HEMOPERFUSION USING HA 330 FILTER AMONG PATIENTS WITH SEPSIS IN ST. LUKE’S MEDICAL CENTER //Kidney International Reports. – 2020. – Т. 5. – №. 3. – С. S293-S294.

Ronco C. et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis //Artificial organs. – 2003. – Т. 27. – №. 9. – С. 792-801.

Saparov А.I., Tobylbayeva Z.S., et al. A Case of Successful Application of HA 330 System for Treatment of Sepsis in a 6-month Old Hematological Patient//National Research Center for Maternal and Child Health, Corporate Fund University Medical Center (CF UMC), Turan Ave 32, Nur- Sultan, Kazakhstan//International Journal of Medical Science and Health Research Vol. 4, No. 04; 2020

Shadvar K, Tagizadiyeh A, Gamari A, A, Soleimanpour H, Mahmoodpoor A: Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm. Blood Purif 2020

Sun S. et al. High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study //Annals of Saudi medicine. – 2015. – Т. 35. – №. 5. – С. 352-358.

Tang Yi, Zhang Ling, Ying Yingying, et al. Hemoperfusion plus contingous veno-venous hemofiltration for patients with sepsis and acute kidney injury [J]. Medical Journal of West China, 2012, 24(2): 233-235, 238.

Wang, Y. T., Fu, J. J., Li, X. L., Li, Y. R., Li, C. F., & Zhou, C. Y. (2016). Effects of hemodialysis and hemoperfusion on inflammatory factors and nuclear transcription factors in peripheral blood cell of multiple organ dysfunction syndrome. Eur Rev Med Pharmacol Sci, 20(4), 745-50.

Zhao Huang Si Rong, Wang, Wei Su, et al. The Removal of Humoral Mediators and the Effect on the Survival of Septic Patients by Hemoperfusion with Neutral Microporous Resin Column [J]. Journal of Therapeutic Apheresis and Dialysis, 2010, 14 (6) : 596-602.

Продукция

Информация

Контакты

Обратная связь